Skip to main content
Clinical Trials/NCT02038998
NCT02038998
Withdrawn
N/A

Unicentric, Phase II, Randomized Study Comparing Periodic Acceleration Versus Static Position in Cerebrovascular Stroke Patients

Fundacion Rioja Salud1 site in 1 countryJanuary 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cerebrovascular Stroke
Sponsor
Fundacion Rioja Salud
Locations
1
Primary Endpoint
NIHSS and Rankin scales
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

Stroke is one of the leading causes of death and disability worldwide. More than 85% of strokes are due to blood vessel occlusion resulting in partial destruction of the brain parenchyma. Current protocols try to re-establish blood circulation as soon as possible through chemical and/or mechanical interventions but new strategies are needed.

Periodic acceleration (pGz) is a non-invasive method consisting in the application of a rocking movement to the patient that ultimately will induce the release of beneficial chemicals from the vascular endothelium (the cells lining the inside of the blood vessels). Application of pGz in an animal model of stroke resulted in a dramatic reduction of associated brain damage.

This trial will investigate whether stroke patients exposed to pGz experiment significantly higher recovery than patients that remained static during their treatment.

Detailed Description

Periodic acceleration (pGz) is a non-invasive method consisting in the application of a rocking movement to the patient that ultimately will induce the release of beneficial chemicals from the vascular endothelium (the cells lining the inside of the blood vessels). Application of pGz in an animal model of stroke resulted in a dramatic reduction of associated brain damage. This trial will investigate whether stroke patients exposed to pGz experiment significantly higher recovery than patients that remained static during their treatment.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
June 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Alfredo Martinez

Group Leader

Fundacion Rioja Salud

Eligibility Criteria

Inclusion Criteria

  • A signed informed consent form must be obtained prior to recruitment
  • Patients with symptoms of acute ischemic stroke
  • Less than 12 hours from initiation of the stroke
  • Age: 18 years or older
  • Capable of following the protocol

Exclusion Criteria

  • Pregnant or lactating women, and women that do not follow a contraceptive plan and may become pregnant
  • Less than 18 years of age
  • More than 12 hours from the initiation of the stroke or when the initiation time is unknown.
  • Hemorrhagic stroke
  • Candidates to receive thrombolytic treatment
  • Spine traumatism or other conditions that may be aggravated by pGz
  • Patients that cannot be properly followed because of phycological, social, familiar, or geographical reasons.

Outcomes

Primary Outcomes

NIHSS and Rankin scales

Time Frame: 0hr, 2hr, 24hr, 48hr, 7ds, 90ds

The NIHSS and Rankin scales will be applied to the patients at the indicated times

Secondary Outcomes

  • Infarct volume(7 days)

Study Sites (1)

Loading locations...

Similar Trials